Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05378945 |
| Consolidated Lead Sponsor | Corxel Pharmaceuticals |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 340 participants (ACTUAL) |
| Registered Start Date | 2022-07-22 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Beijing Hospital | Beijing, China | Open Hospital Dossier -> |
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| ZhuJiang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.